Intensive glucose therapy improves some markers

04/25/2013 | Healio

Older type 2 diabetes patients who underwent intensive glucose-lowering therapy attained better adiponectin, lipid and triglyceride levels at nine months, a study indicated. However, the intensive therapy did not appear to improve cardiovascular outcomes in patients, researchers reported in Diabetes Care.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC